Study number 8548-638
Dates
Oct 15 2025-Dec 12 2025
Location
Madison, Wisconsin
Age
18-55
Gender
Male and Female
Smoker
No
Compensation
$8,378
Group
C 1a OR C 2a
The investigational drug in this research is being developed for the potential treatment of plycythemia vera, which, is a certain kind of cancer where the body produces too many red blood cells.
Women Eligibility Criteria
Body Mass Index (BMI)
Smoking Criteria
Medication Restrictions
Screening Procedures
C1a:
Check-in: Oct 15
Check-out: Oct 18
Check-in: Oct 22
Check-out: Oct 23
Check-in: Nov 12
Check-out: Nov 13
Check-in: Dec 10
Check-out: Dec 11
Follow-up Visits: Oct 30 and Nov 26
C2a:
Check-in: Oct 16
Check-out: Oct 19
Check-in: Oct 23
Check-out: Oct 24
Check-in: Nov 13
Check-out: Nov 14
Check-in: Dec 11
Check-out: Dec 12
Follow-up Visits: Oct 31 and Nov 28